RCHA Rich Pharmaceuticals Announces Completion of
Post# of 72709
Posted On: 02/04/2015 9:49:36 AM
RCHA Rich Pharmaceuticals Announces Completion of the Manufacture of RP-323 Study Drug in Connection with Obtaining FDA's Final Approval of The Investigational New Drug (IND) Application For The Treatment of Acute Myelocytic Leukemia
(0)
(0)Scroll down for more posts ▼